|
|
|
R E S O L U T I O N
|
|
WHEREAS, Hypertrophic Cardiomyopathy Awareness Day is taking |
|
place on February 26, 2025, and this occasion provides a fitting |
|
opportunity to promote better understanding of this health issue; |
|
and |
|
WHEREAS, Hypertrophic cardiomyopathy (HCM) is a chronic |
|
cardiovascular disease that involves thickening of the heart muscle |
|
and can potentially lead to debilitating symptoms and serious |
|
complications, including heart failure, atrial fibrillation, |
|
stroke, and in rare cases, sudden cardiac death; and |
|
WHEREAS, HCM is the most common inheritable heart disease; it |
|
can affect anyone, regardless of age, gender, or ethnicity, and it |
|
has a reported prevalence ranging from 1 in 200 individuals to 1 in |
|
500 individuals in the general population; recent reports show that |
|
the number of people in Texas who have HCM range from 58,000 to |
|
nearly 147,000, although approximately 85 percent of cases remain |
|
undiagnosed; and |
|
WHEREAS, HCM shares symptoms with other common |
|
cardiovascular and pulmonary diseases, such as shortness of breath, |
|
chest pain, fatigue, palpitations, and fainting, and those |
|
similarities make it difficult to accurately diagnose HCM; in |
|
addition, the all-cause mortality risk is three to four times |
|
higher in patients with HCM than that of the general population; it |
|
is important that patients know their medical history and stay |
|
informed about the signs and symptoms of HCM; and |
|
WHEREAS, In order to help identify a risk of both genetic and |
|
congenital cardiac disorders, health care providers conduct |
|
thorough screenings with cardiac health questions; they may also |
|
conduct several tests, including an echocardiogram, a cardiac MRI, |
|
or genetic testing to confirm a family history of HCM, and they must |
|
examine the heart to diagnose HCM; and |
|
WHEREAS, Following a diagnosis of HCM, patients are advised |
|
to work with their health care providers to learn more about the |
|
disease and different management options, such as prescription |
|
medicines and surgical treatments; and |
|
WHEREAS, Hypertrophic cardiomyopathy is a serious and |
|
life-threatening disease, and the observance of Hypertrophic |
|
Cardiomyopathy Awareness Day unites people around the world in |
|
their commitment to improving the quality of life for patients; |
|
now, therefore, be it |
|
RESOLVED, That the House of Representatives of the 89th Texas |
|
Legislature hereby recognize February 26, 2025, as Hypertrophic |
|
Cardiomyopathy Awareness Day and urge all Texans to learn more |
|
about the disease; and, be it further |
|
RESOLVED, That an official copy of this resolution be |
|
prepared for the Hypertrophic Cardiomyopathy Association as an |
|
expression of high regard by the Texas House of Representatives. |